Login / Signup

Ammonium tetrathiomolybdate in the decoppering phase treatment of Wilson's disease with neurological symptoms: A case series.

Oriol De FabreguesJaume ViñasAntoni PalasíManuel QuintanaIgnasi CardonaCristina AugerVíctor Vargas
Published in: Brain and behavior (2020)
ATTM could be a good treatment for the initial treatment of WD with neurological symptoms due to its high efficacy, with a lower rate of neurological deterioration than the drugs currently available, despite the potential adverse effects.
Keyphrases
  • physical activity
  • replacement therapy
  • sleep quality
  • blood brain barrier